These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

233 related articles for article (PubMed ID: 23575964)

  • 1. MicroRNAs and tumor vasculature normalization: impact on anti-tumor immune response.
    Matejuk A; Collet G; Nadim M; Grillon C; Kieda C
    Arch Immunol Ther Exp (Warsz); 2013 Aug; 61(4):285-99. PubMed ID: 23575964
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hypoxia control to normalize pathologic angiogenesis: potential role for endothelial precursor cells and miRNAs regulation.
    Collet G; Skrzypek K; Grillon C; Matejuk A; El Hafni-Rahbi B; Lamerant-Fayel N; Kieda C
    Vascul Pharmacol; 2012; 56(5-6):252-61. PubMed ID: 22446152
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Vessel abnormalization: another hallmark of cancer? Molecular mechanisms and therapeutic implications.
    De Bock K; Cauwenberghs S; Carmeliet P
    Curr Opin Genet Dev; 2011 Feb; 21(1):73-9. PubMed ID: 21106363
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Altered angiogenesis in the tumor microenvironment.
    Hida K; Kawamoto T; Ohga N; Akiyama K; Hida Y; Shindoh M
    Pathol Int; 2011 Nov; 61(11):630-7. PubMed ID: 22029673
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CD40-induced countercurrent conduits for tumor escape or elimination?
    Murugaiyan G; Martin S; Saha B
    Trends Immunol; 2007 Nov; 28(11):467-73. PubMed ID: 17981086
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The apelin/APJ system induces maturation of the tumor vasculature and improves the efficiency of immune therapy.
    Kidoya H; Kunii N; Naito H; Muramatsu F; Okamoto Y; Nakayama T; Takakura N
    Oncogene; 2012 Jul; 31(27):3254-64. PubMed ID: 22037214
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Growing tumor vessels: more than one way to skin a cat - implications for angiogenesis targeted cancer therapies.
    Leite de Oliveira R; Hamm A; Mazzone M
    Mol Aspects Med; 2011 Apr; 32(2):71-87. PubMed ID: 21540050
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tumour endothelial cells acquire drug resistance in a tumour microenvironment.
    Hida K; Akiyama K; Ohga N; Maishi N; Hida Y
    J Biochem; 2013 Mar; 153(3):243-9. PubMed ID: 23293323
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Classical and non-classical proangiogenic factors as a target of antiangiogenic therapy in tumor microenvironment.
    Marech I; Leporini C; Ammendola M; Porcelli M; Gadaleta CD; Russo E; De Sarro G; Ranieri G
    Cancer Lett; 2016 Sep; 380(1):216-26. PubMed ID: 26238184
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Monocyte/macrophage infiltration in tumors: modulators of angiogenesis.
    Dirkx AE; Oude Egbrink MG; Wagstaff J; Griffioen AW
    J Leukoc Biol; 2006 Dec; 80(6):1183-96. PubMed ID: 16997855
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MicroRNAs regulate tumor angiogenesis modulated by endothelial progenitor cells.
    Plummer PN; Freeman R; Taft RJ; Vider J; Sax M; Umer BA; Gao D; Johns C; Mattick JS; Wilton SD; Ferro V; McMillan NA; Swarbrick A; Mittal V; Mellick AS
    Cancer Res; 2013 Jan; 73(1):341-52. PubMed ID: 22836757
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chemokines in tumor-associated angiogenesis.
    Gerber PA; Hippe A; Buhren BA; Müller A; Homey B
    Biol Chem; 2009 Dec; 390(12):1213-23. PubMed ID: 19804363
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Endothelial Progenitors in the Tumor Microenvironment.
    Testa U; Pelosi E; Castelli G
    Adv Exp Med Biol; 2020; 1263():85-115. PubMed ID: 32588325
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Non-coding RNAs regulate angiogenic processes.
    Ghafouri-Fard S; Shoorei H; Mohaqiq M; Taheri M
    Vascul Pharmacol; 2020; 133-134():106778. PubMed ID: 32784009
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tumor exploits alternative strategies to achieve vascularization.
    Bussolati B; Grange C; Camussi G
    FASEB J; 2011 Sep; 25(9):2874-82. PubMed ID: 21628445
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Contribution of Tumor Endothelial Cells in Cancer Progression.
    Hida K; Maishi N; Annan DA; Hida Y
    Int J Mol Sci; 2018 Apr; 19(5):. PubMed ID: 29695087
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Regulation of tumor angiogenesis by microRNAs: State of the art.
    Goradel NH; Mohammadi N; Haghi-Aminjan H; Farhood B; Negahdari B; Sahebkar A
    J Cell Physiol; 2019 Feb; 234(2):1099-1110. PubMed ID: 30070704
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Angiogenesis--a new target for future therapy.
    Pandya NM; Dhalla NS; Santani DD
    Vascul Pharmacol; 2006 May; 44(5):265-74. PubMed ID: 16545987
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular heterogeneity of tumor endothelium.
    Aird WC
    Cell Tissue Res; 2009 Jan; 335(1):271-81. PubMed ID: 18726119
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tumor Hypoxia Regulates Immune Escape/Invasion: Influence on Angiogenesis and Potential Impact of Hypoxic Biomarkers on Cancer Therapies.
    Abou Khouzam R; Brodaczewska K; Filipiak A; Zeinelabdin NA; Buart S; Szczylik C; Kieda C; Chouaib S
    Front Immunol; 2020; 11():613114. PubMed ID: 33552076
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.